Catheter ablation for atrial fibrillation in patients with congestive heart failure

التفاصيل البيبلوغرافية
العنوان: Catheter ablation for atrial fibrillation in patients with congestive heart failure
المؤلفون: Yoshihide Takahashi, Yukihiro Inamura, Kazuya Murata, Masahiko Goya, Tetsuo Sasano, Yutaka Matsumura, Kazuo Eguchi, Akira Sato, Yasuaki Hada, Takashi Ikenouchi, Shunichi Kato, Junichi Nitta, Toshikazu Kono, Tsunehiro Yamato, Miki Kanoh, Tomomasa Takamiya, Giichi Nitta, Ken Negi, Osamu Inaba
المصدر: International journal of cardiology. 333
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Cardiomyopathy, Catheter ablation, 030204 cardiovascular system & hematology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Atrial Fibrillation, medicine, Humans, Sinus rhythm, cardiovascular diseases, 030212 general & internal medicine, Atrial tachycardia, Retrospective Studies, Heart Failure, Ejection fraction, business.industry, Atrial fibrillation, Brain natriuretic peptide, medicine.disease, Treatment Outcome, Heart failure, cardiovascular system, Cardiology, Catheter Ablation, medicine.symptom, Cardiology and Cardiovascular Medicine, business
الوصف: Background We evaluated the 1-year success rate of maintaining sinus rhythm after catheter ablation (CA) for atrial fibrillation (AF) in patients with or without congestive heart failure (CHF). Methods In this single-centre retrospective matched-pair cohort study of 3,018 AF patients who underwent initial CA between January 2012 and June 2018, 227 pairs with (CHF group) or without CHF (control group) were matched using propensity scores. In the CHF group, 108 patients were assigned to the arrhythmia-induced cardiomyopathy (AIC) group whose left ventricular systolic dysfunction was explained only by lasting AF or atrial tachycardia; the remaining 119 had organic heart diseases (non-AIC group). We evaluated the 1-year AF-free survival and changes in clinical findings before and after CA. Results The CHF and control groups showed similar AF-free survival; however, AIC patients had significantly better survival than non-AIC patients. AF recurrence was significantly related to CHF re-hospitalisation, which was significantly more frequent in the non-AIC group than in the AIC group. The clinical outcomes of left atrial dilation, brain natriuretic peptide level, and left ventricular ejection function improved significantly before and after CA in both groups. The degree of improvement was significantly better in the AIC group than in the non-AIC group. Conclusions The 1-year success rate was not significantly different between the CHF and control groups. The 1-year success rate in the AIC group was similar to that in the AIC-control group and was better than that in the non-AIC group. CHF clinical outcomes were improved significantly.
تدمد: 1874-1754
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c548291429bc0a87268e42d3dae7906
https://pubmed.ncbi.nlm.nih.gov/33647363
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....6c548291429bc0a87268e42d3dae7906
قاعدة البيانات: OpenAIRE